Newark, N.J. (September 10, 2024) - The New
Jersey Supreme Court recently held in a consolidated appeal that
incident reports regarding injuries at healthcare facilities were
not protected by Patient Safety Act self-critical analysis
privilege when the facilities did not comply with PSA procedures
(Keyworth v. CareOne at Madison Avenue, consol. with
Bender v. Harmony Village at CareOne Paramus, 2024 N.J.
LEXIS 791 (2024)). The court held the only precondition to applying
"the PSA's privilege is whether the facility performed its
self-critical analysis in procedural compliance with N.J.S.A.
26:2H-12.25(b) and its implementing regulations."
Brugaletta v. Garcia, 234 N.J. 225, 247 (2018). One of
those regulations requires that a facility's patient safety
committee operate independently from any other committee within the
facility. See N.J.A.C. 8:43E-10.4(c)(4). The facilities in these
consolidated appeals did not comply with that procedural
requirement, and the disputed documents were therefore not
privileged. The consolidated case involved a skilled nursing
facility and an assisted living facility, and the decision applies
to all medical facilities.
The defendant facilities did not have separate PSA committees,
likely because nursing homes must already comply with the Federal
Nursing Home Reform Act (FNHRA), 42 U.S.C. §§
1396r(b)(1)(B), 1395i-3(b)(1)(B), which requires nursing homes to
maintain a Quality Assessment and Assurance Committee (QAAC). And
federal regulations require health care facilities to maintain a
Quality Assurance and Performance Improvement (QAPI) program that
focuses on "indicators of the outcomes of care and quality of
life," 42 C.F.R. § 483.75(a), and set forth an identical
structure and purpose for the facility's QAAC to those found in
the FNHRA, see 42 C.F.R. § 483.75(g)(2)(i) to (ii). New Jersey
separately requires assisted living facilities to have Quality
Improvement (QI) programs under N.J.A.C. 8:36-21.1, including
written plans for resident care and ongoing monitoring of resident
services.
The defendants complied with these requirements and certified
that they did so to the court. This was fatal to the PSA privilege
because the defendant facilities did not maintain a separate PSA
committee, and therefore could not maintain the privilege. While
QAAC and QI programs do provide some protection from disclosure
they do not provide the broad protection afforded by the PSA. QAPI
programs afford a narrow privilege that seems to extend only to the
QAAC's internal minutes, working papers, and conclusions, but
not to incident reports or investigations created outside of that
distinct committee. However, these documents would be privileged
under the PSA. It is critical to note that PSA expressly provides
that it "shall not be construed to eliminate or lessen a
[health care facility's] obligation under current law or
regulation to have a continuous quality improvement program."
N.J.S.A. 26:2H-12.25(b). Thus, a facility must have separate PSA,
QAAC and QAPI committees. Based on this decision it is imperative
that all facilities immediately form a separate PSA compliant
patient safety committee.
Generally, the statute requires facilities to "develop and
implement a patient safety plan for the purpose of improving the
health and safety of patients at the facility," N.J.S.A.
26:2H-12.25(b); see N.J.A.C. 8:43E-10.4(a). At a minimum, patient
safety plans must include:
- a patient safety committee, as prescribed by regulation;
- a process for teams of facility staff, which teams are comprised of personnel who are representative of the facility's various disciplines and have appropriate competencies, to conduct ongoing analysis and application of evidence-based patient safety practices in order to reduce the probability of adverse events resulting from exposure to the health care system across a range of diseases and procedures;
- a process for teams of facility staff, which teams are comprised of personnel who are representative of the facility's various disciplines and have appropriate competencies, to conduct analyses of near-misses, with particular attention to serious preventable adverse events and adverse events; and
- (4) a process for the provision of ongoing patient safety training for facility personnel. [N.J.S.A. 26:2H-12.25(b).]
The PSA's corresponding regulations outline the requirements for a patient safety committee in significant detail, including, for example, direction as to how to appoint the chairperson and members; meeting frequency; documentation; regular review protocols; and data analysis of the committee's findings. See N.J.A.C. 8:43E-10.4(c) and (d).
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.